Alternatives to 32 Biosciences
32 Biosciences is a Biotech tool: develops novel therapeutic antibodies for oncology and autoimmune diseases. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotech companies to 32 Biosciences
- Website
Amgen34BiotechThousand Oaks, United States$40.0MA global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.
- Website
Adimab53BiotechLebanon, United States$105.0MAdimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.
- Website
Dren Bio48BiotechSan Carlos, United States$156.0MBiopharmaceutical company developing antibody therapeutics for cancer and autoimmune diseases.
- Website
Cue Biopharma, .62BiotechBoston, United States$10.0MDeveloping engineered biologics to harness the immune system for disease treatment.
- Website
Adicet Bio48BiotechBoston, United States$389.0MClinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.
- Website
BeiGene64BiotechCambridge, United States$358.0MA global oncology company developing and commercializing innovative cancer treatments.
- Website
Caris Life Sciences59BiotechIrving, United States$700.0MCaris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
- Website
Guardant Health57BiotechRedwood City, United States$900.0MGuardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.
- Website PRProNAi Therapeutics55Biotech$115.8M
A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.
- Website
ProteinQure54BiotechCambridge, United States$15.6MBiotech company using AI and computational platforms to design novel peptide therapeutics.
- Website
Integra Therapeutics54BiotechBarcelona, Spain$134.8MBiotech company developing next-generation gene writing tools for advanced therapies.
- Website
Tharimmune53BiotechCambridge, United States$540.0MBiotechnology company developing novel immunotherapies for cancer.
- Website
Leap Therapeutics50BiotechCambridge, United States$189.0MLeap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.
- Website
C4 Therapeutics49BiotechBoston, United States$371.0MBiopharmaceutical company developing novel cancer therapies using targeted protein degradation.
- Website LELeman Biotech48BiotechShenzhen, China$22.7M
Clinical-stage biotech developing AI-driven metabolic immunotherapies for cancer and autoimmune diseases.
- Website ONOneThree Biotech45BiotechNew York City, United States$2.8M
AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.
- Website ALAlpha9 Theranostics44BiotechVancouver, Canada$10.0M
Developing novel radiopharmaceuticals for targeted cancer treatment using advanced molecular imaging and therapy.
- Website
CureVac40BiotechTübingen, Germany$2.1BBiopharmaceutical company developing mRNA-based vaccines and therapeutics for infectious diseases and cancer.
- Website
Sutro Biopharma40BiotechSouth San Francisco, United States$296.4MClinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.
- Website
Intellia Therapeutics40BiotechCambridge, United States$310.0MA clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.
Showing the 20 closest matches. See the rest on the 32 Biosciences profile.
Compare 32 Biosciences head to head
Side by side on what each one does, what it costs, and what real users report.